In clinical studies, the increase was significant (approximately 181 micrograms per liter above baseline) but remained within physiological norms
In one case, we were recommended GLP-1s even though the user was underweight (57 and 110 pounds)
Importantly, efpeglenatides immunogenicity remained relatively low, with few patients developing clinically significant anti-drug antibodies, allowing its safety profile to be viewed as manageable within class expectations
Our Formula contains no gluten, dairy, soy, or artificial preservatives
Dosing & Reconstitution Guide Educational guide for reconstitution and daily dosing Standard / Gradual Approach (3 mL = ~3.33 mg/mL total) Route: Subcutaneous (SC) | Frequency: Once daily Note: The 1:1 blend ratio means tesamorelin and ipamorelin are present in equal amounts per mL
Yes, but only in limited cases